Keywords: HCV; hepatitis C; LT; liver transplantation; DDI; drug-drug interactions; DAAs; direct-acting antivirals; PegINF; peginterferon; RBV; ribavirin; MELD; model of end-stage liver disease; PI; protease inhibitor; PR; peginterferon plus ribavirin; SAEs; seriou
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Current treatment guidelines of chronic hepatitis B: The role of nucleos(t)ide analogues and peginterferon
Keywords: Chronic hepatitis B; Treatment; Guidelines; Nucleos(t)ide analogues; Peginterferon; Cirrhosis; Hepatocellular carcinoma;
Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAg-positive chronic hepatitis B patients treated with peginterferon and adefovir
Keywords: HBV; Combination therapy; Peginterferon; Adefovir; Interferon-gamma-inducible protein-10 (IP-10); Intrahepatic IP-10 mRNA expression;
Research ArticleDaclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection
Keywords: HCV; hepatitis C virus; SMV; simeprevir; PegIFN; peginterferon; RBV; ribavirin; DCV; daclatasvir; ASV; asuneprevir; SVR; sustained virologic response; LLOQ; lower limit of quantitation; AE; adverse event; SVR12; sustained virologic response at posttreatme
Original ResearchFull Report: Clinical-LiverCombination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Keywords: HBV; HBeAg Seroconversion; Virologic Response; Clinical Trial; ALT; alanine aminotransferase; CHB; chronic hepatitis B; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; peginterferon; pegylated interferon-α; S/CO;
Tumefactive multiple sclerosis and hepatitis C virus 2a/2C infection: Dual benefit of long-term interferon beta-1a therapy?
Keywords: Tumefactive multiple sclerosis; Acute disseminated encephalomyelitis; Hepatitis C virus infection; HCV genotype 2a/2c; Interferon beta-1a; Peginterferon;
Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programme
Keywords: Hepatitis C; Telaprevir; HIV; Coinfection; Cirrhosis; Bridging fibrosis; DAA; direct acting antivirals; HAART; highly active anti-retroviral therapy; HCV; hepatitis C virus; HIV; human immunodeficiency virus; PEG-IFN; peginterferon;
Research ArticleRandomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin
Keywords: HCV; hepatitis C virus; PegIFN; peginterferon; danoprevir/r; ritonavir-boosted danoprevir; IFN; interferon; RNA; ribonucleic acid; SVR24; sustained virological response 24Â weeks after end-of-treatment; G; genotype; bid; twice daily; ACTG; AIDS Clinical T
Research ArticleSTARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection
Keywords: HCV; hepatitis C virus; PI; protease inhibitor; PegIFN; peginterferon; RBV; ribavirin; SVR; sustained virologic response; DDI; drug-drug interaction; BID; twice daily; ETS; early treatment success; TD; target detected; TND; target not detected; EVR; ear
Peginterferon plus ribavirin and sustained virological response rate in HCV-related advanced fibrosis: a real life study
Keywords: Hepatitis C; Advanced fibrosis; Peginterferon; Ribavirin
Original ResearchFull Report: Clinical-LiverABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection
Keywords: PEARL-II; Ribavirin-Free; IFN; Interferon-Free Therapy; AE; adverse event; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; DAA; direct-acting antiviral agent; HCV; hepatitis C virus; pegIFN; peginterferon; RBV; rib
My Treatment Approach to Chronic Hepatitis CÂ Virus
Keywords: BOC; boceprevir; FDA; Food and Drug Administration; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HIV; human immunodeficiency virus; PEGINF; peginterferon; RBV; ribavirin; RVR; rapid virologic response; SMV; simeprevir; SOF; sofosbuvir; SVR; sust
Research ArticleSimeprevir with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial
Keywords: HCV; hepatitis C virus; PegIFN; peginterferon; RBV; ribavirin; SVR; sustained virologic response; PI; protease inhibitor; AE; adverse event; QD; once-daily; CONCERTO; Clinical Optimization of New treatment strategy with TMC435 in Combination with peginter
A practical guide for antiviral therapy of chronic Hepatitis C
Keywords: Chronic hepatitis C; Peginterferon; Triple therapy; Direct-acting antivirals interferon-free regimensHepatite crónica C; Peginterferão; Terapêutica tripla; Antivirais de acção directa, regimes sem interferão
Hepatitis B and C in African Americans: Current Status and Continued Challenges
Keywords: Hepatitis B; Hepatitis C; African American; Black; Disparities; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; IFN; interferon; IL; interleukin; MELD; Model
The response to interferon is influenced by hepatitis B virus genotype in vitro and in vivo
Keywords: Genotype; Hepatitis B virus; Interferon; Peginterferon;
Research ArticleImproved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: A randomized study
Keywords: CHC; chronic hepatitis C; PegIFN; peginterferon; SVR; sustained virologic response; HCC; hepatocellular carcinoma; MFS; METAVIR fibrosis score; HCV; hepatitis C virus; SAE; serious adverse event; GGT; gamma glutamyl transpeptidase; ALT; alanine aminotrans
Boceprevir and Treatment of Chronic Hepatitis C
Keywords: Boceprevir; Peginterferon; Ribavirin; Hepatitis C;
Thyroid dysfunction in Turkish patients with chronic hepatitis C receiving peginterferon plus ribavirin in the period of 2005-2010
Keywords: Chronic hepatitis C; Peginterferon; Thyroid dysfunction; Sustained virologic response
Peginterferão α2-a na co-infecção VHB – VH delta – Um caso de duplo sucesso terapêutico
Keywords: Co-infecção; VHB; VHD; PeginterferãoCoinfection; HBV; HDV; Peginterferon
Will Interferon-Free Regimens Prevail?
Keywords: CHC; chronic hepatitis C virus infection; DAA; direct-acting antiviral; HTA; host-targeting agent; Peg-IFN; peginterferon; RAV; resistance-associated amino acid variant; RBV; ribavirin; RVR; rapid virologic response; SVR; sustained virologic response;
Research ArticleValidation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a
Keywords: HBeAg; hepatitis B e antigen; CHB; chronic hepatitis B; NA; nucleos(t)ide analogues; HBV; hepatitis B virus; PEG-IFN; peginterferon; SR; sustained response; HBsAg; hepatitis B surface antigen; ALT; alanine aminotransferase; ULN; upper limit of normal; PCR
Research ArticleRefined prediction of week 12 response and SVR based on week 4 response in HCV genotype 1 patients treated with peginterferon alfa-2a (40KD) and ribavirin
Keywords: RVR; rapid virological response; SVR; sustained virological response; HCV; hepatitis C virus; EVR; early virological response; PCR; polymerase chain reaction; cEVR; complete early virological response; Hepatitis C; Peginterferon; Peginterferon alfa-2a; Su
Research ArticleAntiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study
Keywords: HCV; hepatitis C virus; PegIFN; peginterferon; RBV; weight-based ribavirin; SVR; sustained virologic response; AE; adverse event; DAA; direct-acting antiviral; q.d.; once daily; RVR; rapid virologic response; IC; inhibitory concentration; ECG; electrocard
Research ArticleTelaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan
Keywords: PEG-IFN; peginterferon; RBV; ribavirin; SVR; sustained virological response; SOC; standard of care; DAA; direct acting antiviral; Telaprevir; Chronic hepatitis C; Peginterferon; Ribavirin; Sustained virological response; Genotypes;
Response guided therapy in patients with chronic hepatitis C – Yesterday, today and tomorrow
Keywords: Hepatitis C; Response guided therapy; Peginterferon; Ribavirin; Direct acting antivirals
Research ArticleTreatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin
Keywords: EPO; erythropoietin; HCV; hepatitis C virus; ITT; intention to treat; LT; liver transplantation; PegIFN; peginterferon; PP; Per Protocol; RBV; ribavirin; SVR; sustained virological response; Hepatitis C virus; Peginterferon; Ribavirin; Erythropoietin; Vir
Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients
Keywords: Antinuclear antibody (ANA); Hepatitis C virus; Peginterferon; Ribavirin; Sustained virological response (SVR)
Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B
Keywords: Peginterferon; IL28B Polymorphism; Long-term Follow-up; CI; confidence interval; HR; hazard ratio; IQR; interquartile range; OR; odds ratio; PEG-IFN; peginterferon alfa;
Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus
Keywords: Hepatitis C; Boceprevir; Telaprevir; Safety; Triple Therapy; ADVANCE; a new direction in HCV Care: a study of treatment naïve hepatitis C patient with telaprevir; DAA; direct-acting antiviral; eRVR; extended rapid virologic response; HCV; hepatitis C vir
Liver transplantation in the setting of chronic HCV
Keywords: Recurrent cirrhosis; Cholestatic hepatitis; Donor age; IL28B; Liver biopsy; Elastography; Peginterferon; Ribavirin; Protease inhibitors
Chronic Hepatitis B Treatment: The Cost-Effectiveness of Interferon Compared to Lamivudin e
Keywords: chronic hepatitis B; cost-effectiveness; interferon; lamivudine; peginterferon
Hepatitis crónica por virus de la hepatitis C genotipo 4
Keywords: Hepatitis viral; Genotipo 4; Hepatitis crónica C; Peginterferon; Ribavirina; EpidemiologíaVHC, virus de la hepatitis C; VHC-4, genotipo 4 del VHC; UDVP, usuarios de drogas por vía parenteral; VIH, virus de la inmunodeficiencia humana; CHC, carcinoma hepat
Treatment of hepatitis C virus infection in patients on maintenance hemodialysis: A single United Arab Emirates center experience
Keywords: Hepatitis C; Treatment; Peginterferon; Ribavirin; End stage renal disease; Hemodialysis; Adverse effects;
Research ArticleKinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir
Keywords: Peginterferon; Entecavir; Hepatitis B; Quantitative HBsAg; CHB; chronic hepatitis B; HBV; hepatitis B virus; cccDNA; covalently closed circular DNA; IFN; interferon; NA; nucleos(t)ide analogue; HBsAg; hepatitis B surface antigen; LAM; lamivudine; ADV; ade
Review'Easy to treat' genotypes were not created equal: Can rapid virological response (RVR) level the playing field?
Keywords: pegIFN; peginterferon; ribavirin; RBV; G; genotype (G1-4); SVR; sustained virological response; HCV; hepatitis C virus; RVR/EVR; rapid/early virological response; ALT; alanine aminotransferase; OR/95%CI; odds ratio/95% confidence interval; CHC; chronic he
Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections
Keywords: C209; VX-950; Liver Disease; Clinical Trial; AE; adverse event; EOT; end of treatment; HCV; hepatitis C virus; IL; interleukin; NS; nonstructural; Peg-IFN; peginterferon; PR; peginterferon alfa-2a (180 μg once weekly) and ribavirin (400 mg twice daily);
Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C
Keywords: Direct-Acting Antiviral; Protease Inhibitor; Randomized-Controlled Trial; Liver; AUC24h; area under the plasma concentration-time curve over a 24-hour period; CI; confidence interval; Cmax; mean maximum plasma concentration; Cmin; mean minimum plasma conc
Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C
Keywords: Interferon Therapy; Hepatitis C Clinical Trial; Interferon Nonresponders; Liver Cancer; AFP; α-fetoprotein; ALT; alanine aminotransferase; AST; albumin, aspartate aminotransferase; BMI; body mass index; CI; confidence interval; HAI; histologic activity i
Interferon-Free Regimens: The Near Future, the Likely and the Not So Likely
Keywords: Chronic hepatitis C virus; Peginterferon; Sustained virologic response; Protease inhibitors; Polymerase inhibitors; IL28B genotype;
S-Adenosyl Methionine Improves Early Viral Responses and Interferon-Stimulated Gene Induction in Hepatitis C Nonresponders
Keywords: Interferon Signaling; Transcription Factor; Chronic Hepatitis; cEVR; complete early virological response; DMA; dimethyl arginine; ISG; interferon-stimulated gene; ISGF3; interferon-stimulated gene factor 3; JAK; Janus kinase; Mx1; myxovirus resistance pro
Hepatitis C Virus Treatment-Related Anemia Is Associated With Higher Sustained Virologic Response Rate
Keywords: Adverse Effects of Hepatitis Therapy; Clinical Trial; Liver Disease; Blood Disorders; AE; adverse event; EOT; end of treatment; ESA; erythropoiesis-stimulating agent; Hb; hemoglobin; HCV; hepatitis C virus; IDEAL; Individualized Dosing Efficacy vs Flat Do
Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy
Keywords: Buprenorphine; Hepatitis C treatment; Intravenous drug user; Methadone; Peginterferon
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
Keywords: PCR; polymerase chain reaction; peginterferon; pegylated interferon; SVR; sustained virologic response;
Decline in Male Sexual Desire, Function, and Satisfaction During and After Antiviral Therapy for Chronic Hepatitis C
Keywords: CES-D; Centers for Epidemiologic Studies Depression scale; CI; confidence interval; peginterferon; pegylated interferon; SF-36; Short Form-36; SVR; sustained virological response; Virahep-C; Study of Viral Resistance to Antiviral Therapy of Chronic Hepati
Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C
Keywords: Type 2 diabetes mellitus; Peginterferon; Ribavirin; Sustained virological response; Impaired fasting glucose; Insulin resistance;
Market uptake of new antiviral drugs for the treatment of hepatitis C
Keywords: Hepatitis C; Peginterferon; Market uptake; Market access;
Peginterferon and ribavirin in HCV: Improvement of sustained viral response
Keywords: Chronic hepatitis C; Treatment; Peginterferon; Ribavirin
Liver transplantation in viral hepatitis: Prevention of recurrence
Keywords: hepatitis B; hepatitis C; liver transplantation; hepatitis B immune globulin; peginterferon; ribavirin
The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant
Keywords: HCV; Hepatitis; Haemodialysis; Peginterferon; Ribavirin; Kidney; Transplant